• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 19 of 100
Boston Scientific headquarters as pictured on Jan. 19, 2007. The company acquired device-maker Axonics Inc. for $2.7 billion on Monday.
Health
J&J, Merck, Boston Scientific go on $6.4B buying spree
By Fiona Rutherford and BloombergJanuary 8, 2024
Eli Lilly and Company says its popular drugs Mounjaro and Zepbound, also known as GLP-1s, are not meant for those without obesity or type 2 diabetes.
Health
Eli Lilly cracks down on the use of weight loss drugs Mounjaro and Zepbound for ‘cosmetic’ reasons instead of for diabetes and obesity
By Alexa MikhailJanuary 4, 2024
Ozempic, Wegovy demand so strong Europe’s most valuable listed company plans ‘mega manufacturing facility’
Health
Ozempic, Wegovy demand so strong Europe’s most valuable listed company plans ‘mega manufacturing facility’
By Ellie Harmsworth and BloombergDecember 24, 2023
Pharma will pay rebates in 2024 on 48 drugs whose prices rose more than inflation this year: ‘Let’s call this for what it is—it simply is a rip off’
Health
Pharma will pay rebates in 2024 on 48 drugs whose prices rose more than inflation this year: ‘Let’s call this for what it is—it simply is a rip off’
By Amanda Seitz and The Associated PressDecember 15, 2023
Why business should pay attention to the Supreme Court’s latest mifepristone case
Newsletters
Why business should pay attention to the Supreme Court’s latest mifepristone case
By Emma Hinchliffe and Joey AbramsDecember 14, 2023
Climate change is unleashing a tsunami of infectious diseases–and we have fewer and fewer drugs that can treat them
Commentary
Climate change is unleashing a tsunami of infectious diseases–and we have fewer and fewer drugs that can treat them
By Jayasree K. IyerDecember 11, 2023
Joe Biden
Politics
The White House threatens to cancel the patents of taxpayer-funded drugs if they’re too expensive for patients to afford
By Amanda Seitz, Zeke Miller and The Associated PressDecember 7, 2023
Eli Lilly’s CFO explains why the company’s newest weight-loss drug Zepbound will cost 20% less than the current options
Newsletters
Eli Lilly’s CFO explains why the company’s newest weight-loss drug Zepbound will cost 20% less than the current options
By Sheryl EstradaNovember 29, 2023
McLaren Racing boss Zak Brown
Leadership
How the high-stakes world of Formula 1 racing inspired Sanofi CEO Paul Hudson to deliver more medicines
By Christiaan HetznerNovember 27, 2023
Biden administration is cracking down on pharmacy middlemen, but they’re so powerful it might be too late to help independent drugstores
Finance
Biden administration is cracking down on pharmacy middlemen, but they’re so powerful it might be too late to help independent drugstores
By Arthur Allen and KFF Health NewsNovember 16, 2023
Our changing climate is jeopardizing worker health and productivity. Companies need to adapt their operations
Commentary
Our changing climate is jeopardizing worker health and productivity. Companies need to adapt their operations
By Martine Ferland and Judy MonroeNovember 15, 2023
Europe’s most valuable drugmaker Novo Nordisk is threatening the EU with a shift to the U.S.
Health
Europe’s most valuable drugmaker Novo Nordisk is threatening the EU with a shift to the U.S.
By Ryan HoggNovember 6, 2023
Just 1 sleepless night could actually lead to a dopamine boost—and reverse depression for several days
Mind
Just 1 sleepless night could actually lead to a dopamine boost—and reverse depression for several days
By Erin PraterNovember 3, 2023
picture of four wegovy injections lined up
Health
Novo Nordisk isn’t alone: Sales of Ozempic rival Mounjaro explode as drugmaker Eli Lilly profits from Americans’ weight-loss craze
By Prarthana PrakashNovember 3, 2023
Facade with logo and snow at headquarters of pharmaceutical company Moderna in Cambridge, Massachusetts
Newsletters
Moderna’s CFO on the $25 billion innovation plan to work past the post-COVID slump
By Sheryl EstradaNovember 3, 2023
1...
  • 17
  • 18
  • 19
  • 20
  • 21
...100
Most Popular
Europe
‘It’s only when you see 49-ton trucks in China running on batteries that you realize how serious electrification is’: Octopus Energy CEO Greg Jackson on Europe’s incumbency problemplaceholder alt text
By Kamal AhmedOctober 30, 2026
Real Estate
The Pentagon and Britain are bracing for the power to go out. The ultrawealthy got there first, with backup generators, escape homes, and stockpilesplaceholder alt text
By Sydney LakeOctober 30, 2026
North America
Pentagon orders bases to plan for 90 days without the grid as Britain urges families to stockpile food and waterplaceholder alt text
By Bilin LinOctober 26, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.